|
Jul 18
|
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
|
|
May 15
|
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
|
|
May 15
|
Stereotaxis (STXS) Inks Deal to Buy Access Point Technologies
|
|
May 14
|
Q1 2024 Stereotaxis Inc Earnings Call
|
|
May 14
|
Stereotaxis Inc (STXS) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth and Challenges
|
|
May 13
|
Stereotaxis Reports 2024 First Quarter Financial Results
|
|
May 13
|
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
|
|
Apr 22
|
Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
|
|
Apr 19
|
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
|
|
Mar 8
|
Stereotaxis (STXS) Seeks Clearance for MAGiC Catheter
|
|
Mar 5
|
Stereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call Transcript
|
|
Mar 5
|
Q4 2023 Stereotaxis Inc Earnings Call
|
|
Mar 4
|
Stereotaxis Inc (STXS) Faces Revenue Pressure Amid Strategic Transformation
|
|
Mar 4
|
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
|
|
Mar 4
|
Stereotaxis Reports 2023 Full Year Financial Results
|
|
Nov 28
|
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
|
|
Sep 28
|
AxoGen (AXGN) Moves 6.8% Higher: Will This Strength Last?
|
|
Aug 16
|
Live Long-Distance TeleRobotic Procedures to Highlight Stereotaxis Technology at Asia Pacific Heart Rhythm Symposium
|
|
Jul 20
|
Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023
|
|
Jul 18
|
Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia Patients
|